Pasques, France

Didier Pruneau

This inventor holds 2 USPTO granted patents. Top assignee: Fournier Industrie Et Sante. Active years: 1999-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Didier Pruneau. Retrieved from https://idiyas.com/inventor/didier-pruneau-yx56ne7j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Didier Pruneau

Introduction

Didier Pruneau is a notable inventor based in Pasques, France. With a keen focus on advancements in medical science, he has contributed significantly to the field through his inventions and innovations.

Latest Patents

Pruneau holds two patents, showcasing his expertise in specialized areas. His latest inventions include IL-8 receptor antagonists and benzenesulfonamide derivatives as bradykinin antagonists. These patents illustrate his commitment to developing novel therapeutic agents that have the potential to impact medical treatments significantly.

Career Highlights

Didier Pruneau is currently affiliated with Fournier Industrie Et Santé, where he engages in groundbreaking research and development. His work has helped push the boundaries of medical innovations, contributing to advancements in the pharmaceutical industry.

Collaborations

Throughout his career, Pruneau has collaborated with esteemed colleagues such as Pierre Dodey and Jean-Luc Paquet. These partnerships have fostered a collaborative environment that enhances creativity and fuels innovation in their respective projects.

Conclusion

With a strong foundation in pharmaceutical inventions and a clear vision for future innovations, Didier Pruneau continues to be a driving force in the medical research community. His patents reflect not only his individual creativity but also the collaborative efforts within his team, supporting advancements that could benefit countless patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…